Latest News
Constance Schultsz is a medical microbiologist and professor of Global Health. She has represented Amsterdam UMC on the NCOH Executive Board since 2021. In this interview she tells us about what motivates her, and gives us a glimpse into her life outside the hospital. “I sing and like to go to concerts. Bruce Springsteen’s concert at the Malieveld was a highlight for me.”
A line-up of diverse and very inspiring speakers will present at the NCOH Annual Scientific Meeting 2024 in Amsterdam on 30 May on the topic of Microbiology, food, and our changing climate: Consequences, challenges and solutions.
Wild rodents can host a great diversity of zoonotic pathogens. Rodents that live close to humans increase the likelihood of transfer of such pathogens.
NCOH Student Travel Grant
The NCOH awards a number of travel grants to PhD students of NCOH Partners selected to present their abstract at an international One Health-related academic conference.
Leading scientists Jeremy Farrar, Marion Koopmans, and Ron Fouchier will take you into the world of new infectious diseases outbreaks and show you how we can prepare for these outbreaks.
People who live in the vicinity of a goat farm have a higher chance of developing pneumonia. That was demonstrated by the study “Livestock farming and the health of neighbouring residents (VGO)”, which was carried out in Oost-Brabant and Noord-Limburg. The possible causes of this are still not known. On behalf of the Ministry of Health, Welfare and Sport and the Ministry of Economic Affairs and Climate Policy, IRAS (Utrecht University), RIVM, Wageningen Bioveterinary Research (Wageningen University and Research) and NIVEL have started a follow-up study (VGO-III).
NCOH Partners are involved in a recently-granted One Health European Joint Programme, which started last January. In the One Health EJP, 39 partners from 19 EU member states are gathered to create a sustainable European One Health framework by integration and alignment of medical, veterinary and food institutes through joint programming of research agendas matching the needs of European and national policy makers and stakeholders. In the Netherlands, these organisations are already collaborating closely to counteract the threat of emerging zoonoses and antimicrobial resistance. The Dutch One Health approach can now also be deployed at EU level. The One Health EJP will run for five years with a total budget of 90 Million Euro.
Antimicrobial resistance (AMR) is a growing problem worldwide, and with few new drugs making it to the market, there is an urgent need for new medicines to treat resistant infections. The COMBACTE (COMBatting AntimiCrobial resisTance in Europe) project aims to give antibiotic drug development a much-needed boost by pioneering new ways of designing and implementing efficient clinical trials for novel antibiotics. COMBACTE (which started in 2013) is part of the New Drugs for Bad Bugs (ND4BB) programme, tackling AMR and is funded by the Innovative Medicines Initiative (IMI) of the EU.
Our partners
